DANIEL J STARKS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL J STARKS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL J STARKS. DANIEL J STARKS is in ABBOTT LABORATORIES ($ABT) and Director in ABBOTT LABORATORIES ($ABT) and Chairman, CEO & President in ST JUDE MEDICAL INC ($STJ) and Director in ST JUDE MEDICAL INC ($STJ) and President and COO in ST JUDE MEDICAL INC ($STJ) and President, CEO & Chairman in ST JUDE MEDICAL INC ($STJ) and Director in UROLOGIX INC ($ULGX).
Latest Insider Trading Transactions of DANIEL J STARKS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, STJ, ULGX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 27 2021 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Grant | A | 0.00 | 1,499 | 0 | 7,021,898 | 7 M to 7 M (+0.02 %) | |
Apr 28 2020 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 1,974 | 0 | 7,020,399 | 7 M to 7 M (+0.03 %) |
Apr 30 2019 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 2,241 | 0 | 7,018,425 | 7 M to 7 M (+0.03 %) |
May 01 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 2,945 | 0 | 7,016,184 | 7 M to 7 M (+0.04 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.87 | 400 | 24,348 | 7,013,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.87 | 107 | 6,513 | 7,012,839 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 1,200 | 73,032 | 7,012,732 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.86 | 293 | 17,831 | 7,011,532 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 1,000 | 60,850 | 7,011,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.85 | 100 | 6,085 | 7,010,239 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.84 | 1,000 | 60,840 | 7,010,139 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.83 | 600 | 36,498 | 7,009,139 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 200 | 12,164 | 7,008,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.82 | 400 | 24,326 | 7,008,339 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 900 | 54,729 | 7,007,939 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.81 | 100 | 6,081 | 7,007,039 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 400 | 24,320 | 7,006,939 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.80 | 300 | 18,239 | 7,006,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 800 | 48,632 | 7,006,239 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.79 | 400 | 24,314 | 7,005,439 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 2,100 | 127,638 | 7,005,039 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.78 | 200 | 12,155 | 7,002,939 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 2,100 | 127,617 | 7,002,739 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.77 | 600 | 36,459 | 7,000,639 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 2,500 | 151,900 | 7,000,039 | 7 M to 7 M (+0.04 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.76 | 175 | 10,632 | 6,997,539 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 2,200 | 133,650 | 6,997,364 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.75 | 1,100 | 66,820 | 6,995,164 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 200 | 12,149 | 6,994,064 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 2,000 | 121,480 | 6,993,864 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.74 | 400 | 24,294 | 6,991,864 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 2,200 | 133,606 | 6,991,464 | 7 M to 7 M (+0.03 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.73 | 1,079 | 65,522 | 6,989,264 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 4,900 | 297,528 | 6,988,185 | 7 M to 7 M (+0.07 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.72 | 1,317 | 79,962 | 6,983,285 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 100 | 6,071 | 6,981,968 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 8,100 | 491,751 | 6,981,868 | 7 M to 7 M (+0.12 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.71 | 700 | 42,494 | 6,973,768 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 4,800 | 291,360 | 6,973,068 | 7 M to 7 M (+0.07 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.70 | 500 | 30,348 | 6,968,268 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 4,400 | 267,036 | 6,967,768 | 7 M to 7 M (+0.06 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.69 | 487 | 29,554 | 6,963,368 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 4,500 | 273,060 | 6,962,881 | 7 M to 7 M (+0.06 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.68 | 103 | 6,250 | 6,958,381 | 7 M to 7 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 2,799 | 169,815 | 6,958,278 | 7 M to 7 M (+0.04 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.67 | 600 | 36,399 | 6,955,479 | 7 M to 7 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.66 | 1,600 | 97,056 | 6,954,879 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,600 | 97,040 | 6,953,279 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.65 | 1,500 | 90,968 | 6,951,679 | 7 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 1,300 | 78,832 | 6,950,179 | 6.9 M to 7 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.64 | 200 | 12,127 | 6,948,879 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.63 | 700 | 42,441 | 6,948,679 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.62 | 1,417 | 85,899 | 6,947,979 | 6.9 M to 6.9 M (+0.02 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 600 | 36,366 | 6,946,562 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.61 | 14 | 848 | 6,945,962 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 700 | 42,420 | 6,945,948 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.60 | 100 | 6,060 | 6,945,248 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.59 | 600 | 36,354 | 6,945,148 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,548 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.58 | 100 | 6,058 | 6,944,448 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.57 | 400 | 24,228 | 6,944,348 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.56 | 500 | 30,280 | 6,943,948 | 6.9 M to 6.9 M (+0.01 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.53 | 100 | 6,053 | 6,943,448 | 6.9 M to 6.9 M (0.00 %) |
Feb 28 2018 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | P | 60.52 | 100 | 6,052 | 6,943,348 | 6.9 M to 6.9 M (0.00 %) |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Option Exercise | M | 33.14 | 336,131 | 11,139,381 | 0 | |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Option Exercise | M | 28.50 | 168,413 | 4,799,771 | 0 | |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | M | 33.14 | 336,131 | 11,139,381 | 6,943,248 | 6.6 M to 6.9 M (+5.09 %) |
Aug 03 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Buy | M | 28.50 | 168,413 | 4,799,771 | 6,607,117 | 6.4 M to 6.6 M (+2.62 %) |
Jul 06 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Payment of Exercise | F | 48.71 | 24,236 | 1,180,536 | 6,438,704 | 6.5 M to 6.4 M (-0.37 %) |
May 02 2017 | ABT | ABBOTT LABORATORIE ... | STARKS DANIEL J | Director | Grant | A | 0.00 | 3,437 | 0 | 6,462,940 | 6.5 M to 6.5 M (+0.05 %) |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 0.00 | 18,316 | 0 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 69.08 | 322,428 | 22,273,326 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 0.00 | 9,693 | 0 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 59.41 | 323,093 | 19,194,955 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 35.27 | 367,512 | 12,962,148 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 34.96 | 480,000 | 16,780,800 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 41.65 | 480,000 | 19,992,000 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Option Exercise | D | 38.59 | 450,000 | 17,365,500 | 0 | |
Jan 06 2017 | STJ | ST JUDE MEDICAL, L ... | STARKS DANIEL J | Director | Sell | D | 0.00 | 6,315,961 | 0 | 0 | 6.3 M to 0 (-100.00 %) |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 0.00 | 9,158 | 0 | 18,316 | |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 0.00 | 9,693 | 0 | 9,693 | |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 0.00 | 10,108 | 0 | 0 | |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Payment of Exercise | F | 79.20 | 3,927 | 311,018 | 6,315,961 | 6.3 M to 6.3 M (-0.06 %) |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 0.00 | 9,158 | 0 | 6,319,888 | 6.3 M to 6.3 M (+0.15 %) |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Payment of Exercise | F | 79.20 | 4,157 | 329,234 | 6,310,730 | 6.3 M to 6.3 M (-0.07 %) |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 0.00 | 9,693 | 0 | 6,314,887 | 6.3 M to 6.3 M (+0.15 %) |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Payment of Exercise | F | 79.20 | 4,335 | 343,332 | 6,305,194 | 6.3 M to 6.3 M (-0.07 %) |
Dec 20 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 0.00 | 10,108 | 0 | 6,309,529 | 6.3 M to 6.3 M (+0.16 %) |
Dec 14 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Director | Option Exercise | M | 30.58 | 500,000 | 15,290,000 | 0 | |
Dec 14 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Director | Payment of Exercise | F | 80.20 | 328,794 | 26,369,279 | 6,299,421 | 6.6 M to 6.3 M (-4.96 %) |
Dec 14 2016 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Director | Buy | M | 30.58 | 500,000 | 15,290,000 | 6,628,215 | 6.1 M to 6.6 M (+8.16 %) |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 0.00 | 9,158 | 0 | 27,474 | |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 0.00 | 9,693 | 0 | 19,385 | |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 0.00 | 10,108 | 0 | 10,108 | |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Payment of Exercise | F | 61.06 | 4,145 | 253,094 | 6,128,215 | 6.1 M to 6.1 M (-0.07 %) |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 0.00 | 9,158 | 0 | 6,132,360 | 6.1 M to 6.1 M (+0.15 %) |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Payment of Exercise | F | 61.06 | 4,387 | 267,870 | 6,123,202 | 6.1 M to 6.1 M (-0.07 %) |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 0.00 | 9,693 | 0 | 6,127,589 | 6.1 M to 6.1 M (+0.16 %) |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Payment of Exercise | F | 61.06 | 4,575 | 279,350 | 6,117,896 | 6.1 M to 6.1 M (-0.07 %) |
Dec 21 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 0.00 | 10,108 | 0 | 6,122,471 | 6.1 M to 6.1 M (+0.17 %) |
Oct 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 40.55 | 120,000 | 4,866,000 | 0 | |
Oct 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Sell | S | 62.68 | 4,214 | 264,134 | 6,112,363 | 6.1 M to 6.1 M (-0.07 %) |
Oct 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Sell | S | 62.35 | 115,786 | 7,219,257 | 6,116,577 | 6.2 M to 6.1 M (-1.86 %) |
Oct 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 40.55 | 120,000 | 4,866,000 | 6,232,363 | 6.1 M to 6.2 M (+1.96 %) |
Jul 31 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 40.55 | 100,000 | 4,055,000 | 120,000 | |
Jul 31 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Sell | S | 73.93 | 100,000 | 7,393,000 | 6,112,363 | 6.2 M to 6.1 M (-1.61 %) |
Jul 31 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 40.55 | 100,000 | 4,055,000 | 6,212,363 | 6.1 M to 6.2 M (+1.64 %) |
Apr 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Option Exercise | M | 40.55 | 100,000 | 4,055,000 | 220,000 | |
Apr 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Sell | S | 72.69 | 29,743 | 2,162,019 | 6,112,363 | 6.1 M to 6.1 M (-0.48 %) |
Apr 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Sell | S | 72.36 | 70,257 | 5,083,797 | 6,142,106 | 6.2 M to 6.1 M (-1.13 %) |
Apr 30 2015 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | Chairman, CEO & Pre ... | Buy | M | 40.55 | 100,000 | 4,055,000 | 6,212,363 | 6.1 M to 6.2 M (+1.64 %) |
Nov 13 2008 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Option Exercise | A | 0.79 | 10,000 | 7,900 | 10,000 | |
Nov 08 2007 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Option Exercise | A | 1.66 | 10,000 | 16,600 | 10,000 | |
Nov 16 2006 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Option Exercise | A | 2.49 | 10,000 | 24,900 | 10,000 | |
Aug 23 2006 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Buy | P | 2.92 | 2,346 | 6,850 | 30,000 | 27.7 K to 30 K (+8.48 %) |
Aug 23 2006 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Buy | P | 3.00 | 2,015 | 6,045 | 27,654 | 25.6 K to 27.7 K (+7.86 %) |
Aug 23 2006 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Buy | P | 3.02 | 700 | 2,114 | 25,639 | 24.9 K to 25.6 K (+2.81 %) |
Aug 23 2006 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Buy | P | 3.03 | 673 | 2,039 | 24,939 | 24.3 K to 24.9 K (+2.77 %) |
Aug 23 2006 | ULGX | UROLOGIX INC | STARKS DANIEL J | Director | Buy | P | 3.04 | 4,266 | 12,969 | 24,266 | 20 K to 24.3 K (+21.33 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Option Exercise | M | 13.14 | 800 | 10,513 | 3,576,000 | |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.99 | 100 | 4,799 | 5,964,792 | 6 M to 6 M (0.00 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.75 | 100 | 4,775 | 5,964,892 | 6 M to 6 M (0.00 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.72 | 400 | 19,088 | 5,964,992 | 6 M to 6 M (-0.01 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.65 | 200 | 9,530 | 5,965,392 | 6 M to 6 M (0.00 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Buy | M | 13.14 | 800 | 10,513 | 5,965,592 | 6 M to 6 M (+0.01 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Option Exercise | M | 13.14 | 59,600 | 783,192 | 3,576,800 | |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.64 | 1,100 | 52,404 | 5,964,792 | 6 M to 6 M (-0.02 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.51 | 200 | 9,502 | 5,965,892 | 6 M to 6 M (0.00 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.50 | 800 | 38,000 | 5,966,092 | 6 M to 6 M (-0.01 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.44 | 900 | 42,696 | 5,966,892 | 6 M to 6 M (-0.02 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.43 | 1,700 | 80,631 | 5,967,792 | 6 M to 6 M (-0.03 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.41 | 700 | 33,187 | 5,969,492 | 6 M to 6 M (-0.01 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.40 | 2,000 | 94,800 | 5,970,192 | 6 M to 6 M (-0.03 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.39 | 1,900 | 90,041 | 5,972,192 | 6 M to 6 M (-0.03 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.38 | 1,000 | 47,380 | 5,974,092 | 6 M to 6 M (-0.02 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.37 | 700 | 33,159 | 5,975,092 | 6 M to 6 M (-0.01 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.36 | 2,000 | 94,720 | 5,975,792 | 6 M to 6 M (-0.03 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.35 | 1,600 | 75,760 | 5,977,792 | 6 M to 6 M (-0.03 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.34 | 4,200 | 198,828 | 5,979,392 | 6 M to 6 M (-0.07 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.33 | 500 | 23,665 | 5,983,592 | 6 M to 6 M (-0.01 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.32 | 1,000 | 47,320 | 5,984,092 | 6 M to 6 M (-0.02 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.31 | 4,800 | 227,088 | 5,985,092 | 6 M to 6 M (-0.08 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.30 | 5,800 | 274,340 | 5,989,892 | 6 M to 6 M (-0.10 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.29 | 1,600 | 75,664 | 5,995,692 | 6 M to 6 M (-0.03 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.28 | 3,100 | 146,568 | 5,997,292 | 6 M to 6 M (-0.05 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.27 | 9,400 | 444,338 | 6,000,392 | 6 M to 6 M (-0.16 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.26 | 4,500 | 212,670 | 6,009,792 | 6 M to 6 M (-0.07 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.25 | 800 | 37,800 | 6,014,292 | 6 M to 6 M (-0.01 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.23 | 1,100 | 51,953 | 6,015,092 | 6 M to 6 M (-0.02 %) |
Feb 23 2006 | STJ | ST JUDE MEDICAL IN ... | STARKS DANIEL J | President, CEO & Ch ... | Sell | S | 47.22 | 2,000 | 94,440 | 6,016,192 | 6 M to 6 M (-0.03 %) |